Počet záznamů: 1  

Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential

  1. 1.
    0544794 - FLÚ 2022 US eng J - Článek v odborném periodiku
    Fears, R. - Akutsu, H. - Alentajan-Aleta, L.T. - Caicedo, A. - Campos de Carvalho, A.C. - Čolić, M. - Cornish, J. - Cossu, G. - Debré, P. - Dierckxsens, Geoffrey - El-Badri, N. - Griffin, G. - Chingo-Ho Hsieh, P. - Inamdar, M.S. - Kumar, P. - Abraham, C.M. - Maciulaitis, R. - Al Mahtab, M. - O’Brien, F.J. - Pepper, M.S. - Meulen, V.T.
    Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential.
    Stem Cell Reports. Roč. 16, č. 8 (2021), s. 1847-1852. ISSN 2213-6711. E-ISSN 2213-6711
    Institucionální podpora: RVO:67985955
    Klíčová slova: biomedical policy * global * regenerative medicine * stem cells
    Obor OECD: Philosophy, History and Philosophy of science and technology
    Impakt faktor: 7.294, rok: 2021
    Způsob publikování: Open access
    https://doi.org/10.1016/j.stemcr.2021.07.003

    Regenerative medicine has great potential. The pace of scientific advance is exciting and the medical opportunities for regeneration and repair may be transformative. However, concerns continue to grow, relating to problems caused both by unscrupulous private clinics offering unregulated therapies based on little or no evidence and by premature regulatory approval on the basis of insufficient scientific rationale and clinical evidence. An initiative by the InterAcademy Partnership convened experts worldwide to identify opportunities and challenges, with a focus on stem cells. This was designed to be inclusive and consensus outputs reflected the diversity of the global research population. Among issues addressed for supporting research and innovation while protecting patients were ethical assessment, pre-clinical and clinical research, regulatory authorization and medicines access, and engagement with patients, policy makers, and the public. The InterAcademy Partnership (IAP) identified options for action for sharing good practice and building collaboration within the scientific community and with other stakeholders worldwide.
    Trvalý link: http://hdl.handle.net/11104/0321869

     
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.